The DSM-5, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, has faced several controversies and criticisms since its release in 2013. One major criticism is the expansion of diagnostic criteria, leading to concerns about overdiagnosis and medicalizing normal behavior. Critics argue that this could result in more people being labeled as having a mental disorder and possibly receiving unnecessary treatment. Additionally, there has been backlash against the influence of pharmaceutical companies on the development of the DSM-5, with some questioning the objectivity of certain diagnoses and treatments. Other controversies include the lack of cultural sensitivity in the diagnostic criteria and the exclusion of certain disorders or symptoms that are considered significant by some mental health professionals.
This mind map was published on 12 August 2024 and has been viewed 68 times.